Want to keep up-to-date?
We are delighted to welcome Edo van Houten to Gilbert as our new Chief Financial Officer. As Gilbert continues to grow, expand its international partnerships and prepare for its next […]
Gilbert is proud to have been selected to be featured as a POSTER at the Respiratory Innovation Summit (RIS) in Orlando, Florida. Hosted by the American Thoracic Society (ATS), the […]
Gilbert further strengthens and expands its IP portfolio with grant of 2 new patents. We are proud to share that 2 new patents of Gilbert have recently been granted in […]
Gilbert to kick off 2026 Series A Investment Roadshow in Basel at the Health.Tech Global Summit, March 3-5.
In Edinburgh Gilbert will reveal for the first time our Smart Precision Inhaler (SPI), the compact, next-gen device that combines advanced physics with everyday usability! The culmination of years of […]
Our CEO Maurits Huigen will be speaking at the LSX Investival Showcase Europe, 17 November, in London, where he will present the Gilbert showcase for the Series A investment round! […]
We are excited to announce that our dear colleague Mehmet Uzumcu will present at the Pulmonary Drug Delivery conference (PDD2025) in Istanbul on June 11th.
Erik van der Heide is the Quality Affairs and Regulations Affair officer for Gilbert. He explains the importance of quality and certification processes in the medical device industry.
Gilbert would like to acknowledge the monumental achievement of the entire team in attaining the ISO 13485:2016 certification by TÜV SÜD, demonstrating the company’s commitment to compliance with the highest level […]
Gilbert is proud to be featured in a publication of Brainport Eindhoven, titled 'Innovation and Impact in Inhalation Therapy from the Heart of the Brainport Region', being one of the […]
Mehmet Uzumcu talks about electrospray and its application in the treatment of pulmonary diseases
We're privileged to announce that we've been selected as one of the esteemed Hello Tomorrow Deep Tech Pioneers. Out of thousands of applications, our Smart Precision Inhaler solution stood out […]
Gilbert's own Scott Fleming talks about Gilbert's Smart Precision Inhaler and why the time is ripe for this innovation. "It has been 20 years since we saw a major innovation […]
Gilbert looks forward to attending the annual DDL (Drug Delivery to the Lungs) conference in Edinburgh from Dec 11th-13th. This year DDL is celebrating its 35th anniversary and this promises […]
The Gilbert team looks forward to attending the International Conference on “Exploring the Future of Inhalation Drug Delivery“, organized by the University of Parma and supported by the Galenus Foundation, […]
The Gilbert team looks forward to attending the European Respiratory Society (ERS) in Vienna from Sept 7th-11th. Our special interest is to catch up on the latest research in inhaled […]
Please meet our new team member Hans Kersbergen! Read all about his position as System Architect and why he joined the Gilbert team.
Gilbert is open for collaboration to redefine treatments for lung patients with an initial interest in improving inhaled anti-infective treatments. Following our recent introduction at the SMI.London Conference on June […]
The Gilbert team will be visiting HLTH Europe 2024, coming 17-20 June in Amsterdam. We look forward to connect with pharma and biotech decision makers to redefine treatment for lung […]
We have changed our company brand from Gilbert Technologies to just ..... Gilbert! This change reflects an underlying change in our legal structure, where Gilbert Innovation, Gilbert Therapeutics and Gilbert […]
The Gilbert team looks forward to exhibiting at SMI London on June 25th. Join us at this 2nd Soft Mist Inhaler conference and learn to make, develop, use, file and […]
Gilbert is a proud sponsor of the 7th European Symposium on Electrohydrodynamic Atomization and Electrospinning 2024. This year ESEE2024 is taking place in Leeuwarden, The Netherlands from April 24-26. We […]
Gilbert is hiring a System Architect based at our office on the High Tech Campus Eindhoven. At Gilbert we are developing a next-generation soft mist inhaler with a revolutionary new […]
The Gerard & Anton Awards ceremony highlights 10 promising start-ups in the Brainport Eindhoven region each year. Gilbert has been selected a one of the 2023 winners. Click here for […]
Dutch MedTech Company Gilbert Raises €7 Million pre-Series A to Redefine Treatment for Lung Patients. Eindhoven, The Netherlands, June 7 2023 – Gilbert, today announced the completion of its €7 […]
Engineering the inhaler of the future What is the most important success factor to bring a medical technology from lab bench to hospital? At the High Tech Campus Eindhoven Technology […]
Gilbert names Scott Fleming Chief Commercial Officer. Click here for the full press release.
Gilbert Announces George Hersbach to serve as Executive Chairman and Transition Role of CEO to Current COO Maurits Huigen. Click here for the full press release.
Interview with our COO Maurits Huigen after the nomination of Gilbert as one of the promising respiratory device solution providers by Medical Tech Outlook Magazine.
The startup company Gilbert R&D B.V., a subsidiary of Gilbert B.V., announces today that it has received funding for the development of a new generation soft mist inhalers for the […]
Belgium UCLouvain Louvain Drug Research Institute (LDRI) and Netherlands MedTech Start-up Gilbert join efforts for improved therapy for Cystic Fibrosis Patients.LDRI receives funding for the development of a long-acting PEGylated […]
MedTech Magazine, December 2018 When it comes to pulmonary drug administration and therapy adherence, it is noted that many of the commercially available inhalers such as Dry Powder Inhalers (DPIs) and […]
Let’s stay in touch!
Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.